Patent · US Active

Kit comprising contiguous nucleobases, including position 76, of RS5745994

US12018086B2 · kind B2 · utility

0Cited by
3References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 2021
Grant dateJun 25, 2024
Priority date
Expiry dateNov 21, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The aspects disclosed herein describe methods of identifying a subject that is non-responsive to anti-TNF therapy. The aspects disclosed herein further provide for a method of selecting a therapy for a subject with Inflammatory Bowel Disease (IBD), and treating the subject with the therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.